Saudi Arabia In-Vitro Diagnostics (IVD) Market 2019-2024 by Immunochemistry, Clinical Chemistry, Hematology, Hemostasis, Microbiology, SMBG, POCT)

Dublin, Feb. 12, 2019 (GLOBE NEWSWIRE) -- The "Saudi Arabia In Vitro Diagnostics (IVD) Market, by Techniques (Immunochemistry, Clinical Chemistry, Hematology, Hemostasis, Microbiology, SMBG, POCT), Applications (Infectious, Cardiovascular Diseases), End User, Companies" report has been added to ResearchAndMarkets.com's offering.

In-Vitro Diagnostic tests provide adequate information about the diseases without interacting directly to the human body. In-Vitro Diagnostic has numerous applications in disease diagnosing such as Infectious Diseases, Oncology, Diabetes, Cardiovascular diseases, and others. IVD is used by physicians and clinicians at the various stages of the patient care pathway in hospitals, laboratories or other healthcare settings. With the increasing disease burden, the number of diagnostic tests in Saudi Arabia is also increasing and so is the In Vitro Diagnostics market of Saudi Arabia. Saudi Arabia IVD Market is poised to reach US$ 700 Million by the year 2024.

With increasing cases of new strains of viruses and epidemic diseases, health experts are innovating unique healthcare solutions to improve the combat and cure for diseases. Among these innovations, In-vitro diagnostics plays a considerable role in saving people's lives by providing accurate diagnosis and prognosis, which further enables improved monitoring and treatment.

Owing to the benefits offered by IVD, there is steady growth in its adoption and usage. Increasing incidences rates of infectious diseases and the lifestyle diseases are few factors, which are driving the Saudi Arabia In-Vitro Diagnostics (IVD) Market.

By Technique - Immunochemistry, Clinical Chemistry and SMBG Driving the Saudi Arabia In-Vitro Diagnostics (IVD) Market

The report studies the market of the following In-Vitro Diagnostics segments: Immunochemistry, Clinical Chemistry, Hematology, Hemostasis, Microbiology, Molecular Diagnostic, Self Monitoring of Blood Glucose (SMBG) and Point of Care Testing (POCT). Due to the rising infectious diseases, cancer cases and a number of diabetics in the Kingdom of Saudi Arabia, it is believed that Saudi Arabia IVD Market will grow effortlessly in the coming years.

By Application - Infectious Disease and Diabetes hold significant market of Saudi Arabia In-Vitro Diagnostics (IVD) Market

On the basis of applications; Saudi Arabia In-Vitro Diagnostics has been broadly segmented into Infectious Diseases, Cardiovascular Diseases, Oncology, Diabetes, and others.

By End User - Government Hospitals & Laboratory holds the Largest Market

The report studies the market of the following End-User segments: Government Labs & Hospitals, Private Labs & Hospitals, and others.

Companies Analysis

Roche, Abbott, Siemens Healthineers, Sysmex Corporation, and Danaher Corporation are some of the top companies operating in the In-Vitro Diagnostics; has been studied thoroughly in the report.

This market research report provides a complete analysis of the Saudi Arabia In-Vitro Diagnostics (IVD) Market, Growth Drivers, Challenges, and their projections for the upcoming years.

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Saudi Arabia
4.1 Population
4.2 Per Capita Healthcare Expenses
4.3 Healthcare Expenditure

5. Saudi Arabia IVD Market (2011-2024)

6. Market Share - Saudi Arabia In Vitro Diagnostics (IVD) (2011 - 2024)
6.1 By Segments
6.2 By Disease

7. Segments - Saudi Arabia IVD Market (2011- 2024)
7.1 Immunochemistry Market
7.2 Clinical Chemistry Market
7.3 Hematology Market
7.4 Hemostasis/Coagulation Market
7.5 Microbiology Market
7.6 Molecular Diagnostic Market
7.7 Self Monitoring of Blood Glucose (SMBG) Market
7.8 Point of Care Testing (POCT) Market

8. Disease - Saudi Arabia IVD Market (2011- 2024)
8.1 Infectious
8.2 Cardiovascular
8.3 Diabetes
8.4 Oncology
8.5 Others

9. End User - Saudi Arabia IVD Market (2011- 2024)
9.1 Public Labs & Hospitals
9.2 Private Labs & Hospitals

10. Company Analysis

  • Abbott
  • Danaher Corporation
  • Roche
  • Siemens Healthineers
  • Sysmex Corporation

For more information about this report visit https://www.researchandmarkets.com/research/2z6c2r/saudi_arabia?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: 
CONTACT: ResearchAndMarkets.com
         Laura Wood, Senior Press Manager
         press@researchandmarkets.com
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
Related Topics: Point-of-Care Diagnostics, Coagulation and Hemostasis Testing, Hematology 

Ads

You May Also Like

CARsgen Therapeutics and CrownBio complete CAR-T study for gastric cancer

Claudin18.2 specific CAR-T cells show tumor elimination in PDX modelsSAN DIEGO, Sept. 13, 2018 ...

Stemline Therapeutics Prices $45 Million Public Offering of Common Stock

NEW YORK, Jan. 20, 2017 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq:STML), a clinical-stage ...

Tyme Technologies to Present at 2017 Marcum Microcap Conference

NEW YORK, June 12, 2017 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (OTCQB:TYMI), a clinical ...